Specific Anti-Xa Activity of LMWH (Kabi 2165, CY216 PK 10169) Against the First International Standard of LMWH: A Collaborative Study

Thromb Haemost 1990; 64(03): 490-491
DOI: 10.1055/s-0038-1647345

Letter to the Editor

Schattauer GmbH Stuttgart

M D Dautzenberg

^*Laboratoire Central d’Hématalogie Hôpital NECKER-Enfants Malades, Paris, France

,

L Bara

^**Laboratoire de Thrombose Expérimentale Faculté de Médecine, Paris, France

,

P Cornu

^*Laboratoire Central d’Hématalogie Hôpital NECKER-Enfants Malades, Paris, France

,

M Samama

^**Laboratoire de Thrombose Expérimentale Faculté de Médecine, Paris, France

References
1 Barrowcliffe TW, Curtis AD, Johnson EA, Thomas DP. An International Standard for low molecular weight heparin. Thromb Haemostas 1988; 60: 1-7
2 Barrowcliffe TW, Curtis AD, Tomlinson TP, Hubbard AR, Johnson EA, Thomas DP. Standardization of low molecular weight heparin: a collaborative study. Thromb Haemostas 1985; 54: 675-680
3 Bara L, Samama MM. The need for standardization of low molecular weight heparin (LMWH). Thromb Haemostas 1986 56. 418 (Letter).
4 Fareed J, Hoppensteadt D, Walenga JM, Huan X, Messmore HL. Validity of the newly established low molecular weight heparin. Standard in cross referencing low molecular weight heparins. Haemostasis 1988; 18 suppl (Suppl. 03) 33-47
5 Hemker HC. A standard for low molecular weight heparin. Haemostasis 1989; 1: 1-4